Did You Know? Puerto Rican Pharma Manufacturing
Puerto Rico is home to the manufacturing plants for many of the world’s top pharmaceutical and medical device companies, providing a steady stream of treatments to the neighbouring US market…
The CDI mission is to empower research and development in proteomics with proprietary technologies, making possible — today — the protein discoveries of tomorrow. CDI’s HuProt protein microarrays and related services make it possible to perform rapid and efficient analyses of thousands of protein interactions using minimal amounts of valuable research or clinical samples.
The company’s microarray-powered monoclonal antibodies (MAbs] and MAb-related services provide unprecedented levels of specificity. Our system of antibody production is part of the NIH Protein Capture Reagents program and is currently working to produce truly mono-specific antibodies to human transcription factors.
CDI has patents in process for technologies to increase high through put analysis of protein-protein interactions as well as high throughput development of antibodies and identification of biomarkers
At CDI we believe that partnering with both companies and academic scientists is the path to mutual success. So please contact our business development professionals for possible collaborations or partnerships.
The Company has locations in Baltimore, Maryland and in Mayaguez, Puerto Rico.
Contact details
Guanajibo Research and Innovation Park
4005 Street B, Road 114 Km 1.3
Mayaguez, PR 00682
USA
T: 787-806-4010
F: 787-806-4006
www.cdi-lab.com
Puerto Rico is home to the manufacturing plants for many of the world’s top pharmaceutical and medical device companies, providing a steady stream of treatments to the neighbouring US market…
CRB is a global consulting, design and construction services firm specialized in the life sciences industry. Tom Forester, general manager of CRB Caribe, based in Puerto Rico, shares the developments…
Giuseppe Allocca, Pfizer’s site leader for its Vega Baja & Barceloneta operations in Puerto Rico, highlights the importance of Pfizer’s manufacturing operations on the island, with 14 of the company’s…
Lucy Crespo, CEO of the Puerto Rico Science, Technology & Research Trust, takes stock of the Trust’s main achievements since outlining its strategic plan in 2015. She also highlights her…
After climbing through the ranks from sales representative to leading business units at Eli Lilly Canada, François Gilbert took the reins of Eli Lilly’s Puerto Rican affiliate last year. Among…
Charil Pabón, Owner & President of Pharma Consulting Corporation (PCC), explains how the decreasing demand for validation services in Puerto Rico prompted the company to expand in new business areas…
Puerto Rico has long been known for its pharma manufacturing prowess, but multinational companies are increasingly looking to conduct clinical trials there, thanks to strong institutional support, a strong example…
Leobardo Hidalgo, who lived in Puerto Rico as a child, recently came back to the island to head commercial operations at the local BMS affiliate, which has been performing remarkably…
Lcdo. Juan Santiago – EIT, President of the Colegio de Químicos Puerto Rico, explains the far-reaching role of chemists in Puerto Rico’s industry, their current challenges and the goal of…
Ricardo Zayas of US manufacturer Romark, highlights the company’s ambition to make Puerto Rico its operations and manufacturing headquarters. Currently in the scale-up phase, Zayas aims to expand the capacities…
David Foster, president and co-founder of Isla Pharmaceuticals, explains the rationale behind selecting Puerto Rico as a base for the company, which aims to develop treatments for mosquito-borne disease. He…
Dr David Lenihan, president of Ponce Health Sciences University (PHSU) in Puerto Rico, highlights the crucial role the institution plays in tackling the cultural deficit in healthcare on the US…
See our Cookie Privacy Policy Here
